FDA Reverses Office Order, Lets Staff Work From Home
THURSDAY, April 10, 2025 (HealthDay News) — Weeks after ordering staff back to the office,...
Read More
Pharmacy
2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes
THURSDAY, April 10, 2025 (HealthDay News) — Among U.S. adults without diabetes, the use of...
Read More
Medical Cannabis Improves Health-Related Quality of Life With Chronic Conditions
WEDNESDAY, April 9, 2025 (HealthDay News) — Prescribing medical cannabis to patients with...
Read More
Low LDL-C Levels Linked to Reduced Risk for Dementia
WEDNESDAY, April 9, 2025 (HealthDay News) — Low low-density lipoprotein cholesterol (LDL-C)...
Read More
AAN: Tolebrutinib Slows Disability in Nonrelapsing Secondary Progressive MS
WEDNESDAY, April 9, 2025 (HealthDay News) — Tolebrutinib, a brain-penetrant and bioactive...
Read More
Only Half of U.S. Adults Can Afford Health Care and Prescriptions
WEDNESDAY, April 9, 2025 (HealthDay News) — The inability to pay for health care has reached...
Read More
Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes
TUESDAY, April 8, 2025 (HealthDay News) — For patients with diabetes, semaglutide use is...
Read More
AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease
TUESDAY, April 8, 2025 (HealthDay News) — For patients with Parkinson disease with motor...
Read More
Biden Plan to Expand Obesity Drug Coverage Is Rejected
MONDAY, April 7, 2025 (HealthDay News) — The Trump administration has decided not to expand...
Read More
Rates of Dissatisfaction High for Hidradenitis Suppurativa Care
MONDAY, April 7, 2025 (HealthDay News) — The rates of respondent dissatisfaction with...
Read More
Postpartum Hormonal Contraceptives Tied to Higher Depression Risk
THURSDAY, April 3, 2025 (HealthDay News) — Use of hormonal contraceptives postpartum is...
Read More
Zepbound Now Available Through Hims AND Hers
WEDNESDAY, April 2, 2025 (HealthDay News) — The telehealth company Hims & Hers Health is...
Read More
FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
WEDNESDAY, April 2, 2025 (HealthDay News) — The U.S. Food and Drug Administration has...
Read More
Prevalence of Prescription Stimulant Misuse High in U.S. Adults
TUESDAY, April 1, 2025 (HealthDay News) — The prevalence of prescription stimulant misuse...
Read More
Common Photosensitizing Drugs Increase Skin Cancer Risk
TUESDAY, April 1, 2025 (HealthDay News) — Some commonly prescribed photosensitizing drugs...
Read More
FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors
MONDAY, March 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved...
Read More
Evidence Supports Continuing Buprenorphine for Acute Pain in Those With Opioid Use Disorder
MONDAY, March 31, 2025 (HealthDay News) — For patients with opioid use disorder (OUD),...
Read More
Guideline Adherence Suboptimal for Chlamydia, Gonorrhea Treatment
MONDAY, March 31, 2025 (HealthDay News) — Across primary care practices, guideline adherence...
Read More
Pelabresib Plus Ruxolitinib Improves Underlying Myelofibrosis
THURSDAY, March 27, 2025 (HealthDay News) — Pelabresib, a bromodomain and extraterminal...
Read More
Kansas and Ohio Report Surge in Measles Cases Amid Outbreaks
THURSDAY, March 27, 2025 (HealthDay News) — A measles outbreak in Kansas has rapidly...
Read More